Updated April 2026

CompoundPulse vs TradingView:
An Honest Comparison

TradingView wins when customization is the edge. CompoundPulse wins when clarity is the edge.

Written by the CompoundPulse team · Last updated April 2, 2026

Try CompoundPulse Free — No Credit CardJump to Comparison ↓
Stay with TradingView if
  • → Charting is the center of your workflow
  • → You write or rely on Pine Script
  • → You depend on community-published scripts
  • → You publish ideas or follow others publicly
  • → Your layouts, alerts, and habits live there
Switch to CompoundPulse if
  • → You want one research workflow, not five tabs
  • → You do not code and do not want to
  • → You trade stocks, crypto, forex, and futures
  • → You want to test ideas before risking capital
  • → Your problem is fragmentation, not indicator count

Start here

TradingView is still the retail charting benchmark. Pretending otherwise would make this page less useful, not more. If your edge comes from custom layouts, scripting, and living inside the chart, that still matters.

TradingView is strongest when charting is the whole job. CompoundPulse wins when the chart is no longer enough to finish the job.

The real question is whether charting alone is still enough.

TradingView is for traders whose edge is inside the chart. CompoundPulse is for traders whose edge is in the decision before the order.

Who this comparison matters for most

  • → Active or swing traders paying for charting and still opening five other tabs
  • → Multi-asset traders moving between stocks, crypto, forex, and futures
  • → Traders who do not want to learn Pine Script just to validate an idea
  • → Anyone questioning whether what they pay TradingView reflects what they actually use

If you write Pine Script daily or publish chart ideas to an audience, this comparison is still relevant — but your switching cost is higher and you know it.

Where TradingView is genuinely better

Chart engine maturity

TradingView's charting is refined because it has been refined for over a decade. Layouts, responsiveness, indicator layering, replay, and overall smoothness reflect years of iteration. If you spend hours inside a single chart and notice every bit of friction, that gap is real. CompoundPulse does not claim otherwise.

Pine Script

This is TradingView's deepest moat. If your process depends on custom indicators, proprietary strategies, or alerts built around logic you wrote, Pine Script is a genuine reason to stay. TradingView is not just a charting platform — it is a charting platform you can reshape around your own thinking. CompoundPulse has no scripting layer.

Community and script ecosystem

Community-built indicators, invite-only scripts, and public trade ideas are a real part of how many users work. If specific community authors, tool libraries, or social features are embedded in your daily process, that ecosystem does not exist on CompoundPulse.

If charting is your home, TradingView feels like home

Many users stay not because of a single feature, but because their layouts live there, their scripts live there, and the speed of the workflow is native to them. That kind of built-up habit is not a weakness — it is a real reason to stay.

When TradingView stops fitting

Many traders are using a charting-first product to solve a workflow that is no longer charting-first. It usually looks like this:

  • You chart on TradingView.
  • Tab out for a screener.
  • Tab out for insider data.
  • Tab out for options context.
  • Tab out for macro orientation.
  • Tab out for earnings or economic events.
  • The platform that was supposed to be central is now one tab in a scattered decision process.

That is the real pain. Not "I need more indicators." When the job is not just charting but actually deciding, charting alone stops being enough.

Pricing: the honest version

Light users can use TradingView affordably. Some can use it free. Active traders who need higher plan limits, more indicators per chart, and real-time data across multiple markets typically move up tiers — and TradingView's support docs are explicit that professional real-time exchange data is a separate purchase on top of any subscription plan.

PlanAnnual priceIndicators / chartExchange data
Free$02–315-min delayed
Essential~$179/yr5Delayed — add-ons extra
Plus~$359/yr10Some exchanges included
Premium~$719/yr25Most exchanges — add-ons still apply
Ultimate~$1,619/yrUnlimitedBroader coverage

Source: TradingView pricing page. Exchange data add-ons listed separately. Verified April 2026.

Feature comparison

TradingView Premium vs CompoundPulse. April 2026. The table holds the features — the sections above hold the decision.

FeatureTradingViewCompoundPulse
Professional charting✓ Best-in-class✓ 121 indicators
Pine Script / custom scripting✓ Best-in-class
Community script library✓ Thousands of scripts
Social / idea publishing
Point-and-figure charts✓ (paid)✓ Auto box size + trend lines
Relative Rotation Graphs (RRG)✓ (paid)✓ JdK RS-Ratio + 8-week trails
Chart replay mode✓ (paid tiers)
Saved chart layouts
Stock screener✓ (limited on free)✓ 30+ filters, 8,000+ stocks
Fundamental screening (P/E, EPS, margins)Limited✓ 20+ metrics
No-code backtesting✗ Requires Pine Script
Live heatmap (500+ stocks, 7 timeframes)
Insider trading tracker
Options flow (real volume, IV, strikes)✓ Live data
Asset correlation matrix
Economic calendar (FOMC, CPI, NFP)Basic✓ With impact ratings
Paper trading simulator✓ (paid tiers)
Crypto coverage✓ Charts + data✓ 36+ pairs
Forex coverage✓ Charts + data✓ 30+ pairs
Futures/commodities✓ Charts + data
Per-exchange data feesYes — separate add-onsNo
Feature gating by planYesNo — full access
Free access✓ Free tier (limited)✓ Free tier + 7-day premium trial

Where CompoundPulse is the stronger choice

If you do not code, backtesting on TradingView is mostly theoretical. On CompoundPulse, it is usable.

TradingView's Strategy Tester requires Pine Script. Most retail traders do not write Pine Script — which means most retail traders cannot backtest on TradingView. CompoundPulse makes it usable: no-code, with equity curve and drawdown stats. If knowing whether a setup has historically worked matters before you size into it, this is the gap.

If insider buying matters to conviction, it should not require a separate subscription

When executives buy or sell their own stock, it is documented and legally disclosed. CompoundPulse surfaces that data in the same session you are already charting. TradingView has no insider data. For swing and fundamental traders, this is typically a separate paid service elsewhere.

The heatmap answers a different question than the chart does

The CompoundPulse heatmap renders 500+ U.S. equities simultaneously, sized by real market cap, across 7 timeframes — 1D, 1W, 1M, 3M, 6M, 1Y, and YTD. The question is not just "what moved today." It is "what has been building over three months." TradingView does not have this.

One place to stay oriented across every market you trade

TradingView supports multi-asset charting, but real-time data for each market may require a separate purchase. CompoundPulse covers 36+ crypto pairs, 11+ forex pairs, and commodity futures alongside equities — in the same dashboard, same subscription.

One price. No exchange-fee puzzle.

No per-exchange add-ons. No indicator limits to upgrade. No feature tiers. For a trader who wants to spend their energy on the market instead of the pricing page, that clarity is worth something.

If you need a charting engine, stay with TradingView. If you need a complete decision workflow, that is the opening for CompoundPulse.

You probably should not switch if…

  • → Pine Script is central to your edge
  • → You depend on community-built indicators you cannot get elsewhere
  • → Your workflow — layouts, alerts, scripts — is native to TradingView
  • → Tick-level chart precision is a hard requirement
  • → You publish ideas and value TradingView's audience

If charting is your home and TradingView still feels like home, stay.

You should seriously consider CompoundPulse if…

  • → You are paying for TradingView but still need other tools to finish the research
  • → You do not code and do not want to learn scripting just to test an idea
  • → Your real problem is fragmentation — not indicator count
  • → You want insiders, options, and backtesting in the same place you chart
  • → Your goal is fewer bad trades, not more chart customization

Frequently asked questions

Can CompoundPulse replace TradingView?

For most non-scripting traders, yes. For Pine Script users or people who depend on community scripts, not fully. It depends on which part of TradingView you actually use daily.

Does CompoundPulse have backtesting?

Yes — no-code, with equity curve and drawdown stats. If you do not code, backtesting on TradingView is mostly theoretical. On CompoundPulse, it is usable.

Does TradingView have insider trading data?

No. CompoundPulse tracks executive buys and sells as part of the base subscription.

How much does TradingView cost for an active trader?

It depends on use. Light users can stay affordable. Active traders who need more plan limits plus real-time data often move up tiers and add exchange data separately — TradingView's own docs confirm professional real-time market data is a separate purchase on top of any plan.

Is TradingView still better for charting?

For chart engine maturity, Pine Script, and community depth — yes. CompoundPulse provides professional charting with 75+ indicators, which covers most traders. If custom scripting is your core edge, TradingView has earned that position.

Does CompoundPulse offer a free trial?

7-day free trial. No credit card required.

More comparisons
vs Finvizvs Webullvs StockChartsvs Screener.inAll comparisons

See if CompoundPulse covers your workflow.

Free tier available, no credit card. Full premium access for 7 days.

Start Free →

Free tier always available · No credit card required